NOS2 and colitis: Considering that expression of both COX-2 and iNOS is regulated by NF-κB [50,51] the observed inhibition of NF-κB and its downstream effectors, COX-2 and iNOS, can be crucial for the protective role played by AphaMax® treatment in DNBS colitis rats.